The world’s first-ever genome-wide association study, led by the Yottabyte Epigenome Research Group at Rutgers University, found a link between the Yottabyte Epigenome and Alzheimer’s disease, diabetes and leukaemia. It also found a link between the Yottabyte Epigenome pattern and higher rates of disease and deaths in people with diabetes and leukaemia.